AncestryHealth service

AncestryHealth launched to offer actionable health insights

The offering includes two services: AncestryHealth Core, a one-time, array-based service; and AncestryHealth Plus, a membership service using NGS technology.
23andMe diabetes test

23andMe adds type 2 diabetes screening to its Health & Ancestry test

The diabetes risk was calculated from the analysis of data 23andMe collected from more than 2.5 million customers who opted in to its research.
Genomind interface

DrChrono, Genomind team-up to let doctors order personalized genetic tests for doctors

When a physician orders test kits through the DrChrono EHR platform, it will capture patient demographics and applicable clinical information.
OptraGURU

Alexa-powered OptraGURU launches as the first conversational digital genetic assistant

It aims to change the way consumers, genetic counselors, and scientists interact with genetic data and how they engage with genetic testing providers.
Illumina Accelerator

Helix, Illumina Accelerator team-up to foster development of DNA-powered products

Select startups will have access to Helix's team of experts in next-generation sequencing and bioinformatics, applied genomics, regulatory affairs and more.
embodyDNA

Lose It!’s embodyDNA launched as the first in-app DNA-based weight loss plan

Developed in collaboration with Helix, the feature offers customized recommendations on food/beverage consumption and physical activities.
Helix marketplace

Helix launches online marketplace for DNA-powered products

Accessible from Helix.com, the marketplace was created in partnership with a disparate group of companies, app makers and healthcare institutions.
Face2Gene LABS

FDNA launches Face2Gene LABS to accelerate genetic disease diagnoses

The company is teaming-up with two of the most reputable genomics testing labs in the world - GeneDx and Blueprint Genetics.
Shire - PatientsLikeMe

PatientsLikeMe, Shire working together to study rare genetic diseases

The multi-year deal involves the two companies working together to engage patients and caregivers at every stage of their journey.
23andMe

FDA greenlights 23andMe’s request to market direct-to-consumer genetic health risk reports

Genetic risk reports for Alzheimer's disease, Parkinson's disease and Hereditary Thrombophilia included in the FDA authorization, among others.